Global Spinal Allografts Market – Industry Trends and Forecast to 2031

척추이식 시장 분석 및 규모

최소 침습 척추 수술에서 척추파 동종이식은 조직 손상을 줄이고 회복 시간을 단축하여 수술을 용이하게 하는 데 중요한 역할을 합니다. 척추파 동종이식은 최소 침습 척추 융합 및 척추간 융합 수술에서 필수적인 이식 재료로, 뼈 성장을 위한 지지대를 제공하고 척추 융합을 촉진합니다. 최소 침습 기술과의 호환성 덕분에 외과의는 작은 절개로 수술을 수행하여 주변 조직의 손상을 최소화하고 환자의 수술 후 통증을 줄일 수 있습니다.

글로벌 척추 이식편 시장 규모는 2023년에 36억 9천만 달러로 평가되었으며, 2031년까지 51억 1천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 4.15%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

시장 정의

Spine Wave Alografts는 척추 수술 솔루션에 중점을 둔 선도적인 의료 기술 회사인 Spine Wave가 개발한 특수 골 이식 재료입니다. 이러한 이종 이식은 인간 조직 기증자로부터 유래되었으며 뼈의 구조적 무결성과 골전도 특성을 유지하면서 세포 성분을 제거하도록 처리되었습니다. 이는 융합 수술을 포함한 다양한 척추 시술에서 뼈 성장을 촉진하고 척추 융합을 용이하게 하며 척추 안정성을 회복하는 데 사용됩니다. Spine Wave Alografts는 척추 개입을 받는 환자의 뼈 결함을 해결하고 치유를 촉진하기 위한 다재다능하고 신뢰할 수 있는 옵션을 외과의에게 제공합니다.

척추이식 시장 동향

운전자

• 척추 질환 유병률 증가로 인해 척추파 이식편 채택이 촉진됨

전 세계적으로 퇴행성 디스크 질환, 척추관 협착증, 척추 골절과 같은 척추 장애로 고통받는 사람이 증가함에 따라 척추 불안정성을 해결하고 통증을 완화하며 기능을 회복하기 위한 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 척추파 이식편은 척추 융합 수술에 생물학적으로 호환되는 솔루션을 제공하여 외과의에게 뼈 성장을 촉진하고 척추 융합을 용이하게 하는 다재다능한 이식 재료를 제공합니다. 의료 서비스 제공자가 척추 개입에 대한 증가하는 수요를 충족하고자 하면서, 인구에서 만연한 다양한 척추 장애를 해결하는 효능에 힘입어 척추파 이식편 채택이 증가할 것으로 예상됩니다.

• 증가하는 기술 발전으로 척추 수술이 향상됩니다.

기술적 발전에는 수술 기법, 영상 양식 및 생체재료의 혁신이 포함됩니다. 향상된 영상 기술은 보다 정확하고 계획된 진단을 가능하게 하는 반면, 최소 침습 수술 기법은 환자의 외상과 회복 시간을 줄여줍니다. 척추파 이식편은 현대 수술 관행에 점점 더 통합되어 이러한 발전의 혜택을 누리고 있으며, 외과의에게 뼈 융합을 촉진하고 척추 장애를 해결하기 위한 다양한 옵션을 제공합니다. 외과의가 더 나은 결과를 추구하고 환자가 덜 침습적인 시술을 요구함에 따라, 척추파 이식편의 채택은 고급 척추 수술 기법과의 호환성과 효율적인 뼈 치유 및 척추 안정화를 촉진하는 능력에 의해 촉진됩니다.

기회

• 고령화 인구 증가로 인해 전문 진단 솔루션에 대한 수요 증가

As individuals age, they are more susceptible to degenerative spine disorders such as osteoarthritis, spinal stenosis, and vertebral fractures. Consequently, there is a rising demand for spinal interventions, including fusion surgeries utilizing allografts, to address these conditions and alleviate associated symptoms. The expanding elderly demographic worldwide amplifies the need for effective treatment options to maintain mobility, relieve pain, and improve overall quality of life. This demographic shift underscores the importance of spine wave allografts in addressing the unique challenges of age-related spinal disorders, driving growth in the market for these specialized bone grafting materials.

• Increasing Healthcare Expenditure Leads to Rise in Enhanced Patient Outcomes

As healthcare budgets expand, there is a greater capacity for investment in advanced spinal surgery techniques and products. This includes increased adoption of biologic solutions such as spine wave allografts, which offer improved bone healing and reduced complication rates compared to synthetic alternatives. With higher healthcare spending, hospitals, and healthcare facilities are more inclined to invest in innovative spinal surgical solutions to enhance patient outcomes and satisfaction.

Restraints/Challenges

• High Surgical Complexity Becomes a Challenge for Healthcare Providers

The intricate nature of spinal procedures and the potential risks associated with using allograft materials. Surgeons require specialized training and expertise to perform spinal surgeries using allografts, which limits the adoption of these procedures. Moreover, the variability in patient anatomy and the need for precise placement of allografts increase the complexity further, leading to potential complications and a reluctance among surgeons to adopt these techniques extensively.

• Regulatory Challenges Limit the Availability of Spine Wave Allografts

Compliance with complex regulatory frameworks, including approval processes and quality standards, can be time-consuming and expensive for manufacturers. Delays in obtaining regulatory clearance or navigating compliance hurdles can hinder market entry and expansion efforts, limiting the availability of spine wave allografts in certain regions. These challenges may impede the growth potential of spine wave allografts by increasing barriers to entry and influencing market dynamics.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global laboratory information management systems (LIMS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In July 2022, AlloSource launched its latest innovation, a new microfiber demineralized bone allograft designed explicitly for spine procedures. This development underscores AlloSource's commitment to advancing surgical techniques in spinal surgery by providing surgeons with advanced biomaterials to enhance patient outcomes
• In June 2022, AlloSource launched its latest product offering: a new microfiber demineralized bone allograft. This announcement highlights the company's continuous efforts to advance medical solutions, particularly bone grafting procedures. The introduction of this innovative product signifies AlloSource's dedication to meeting the evolving needs of healthcare professionals and improving patient care
• In July 2020, Spine Wave announced the commercial launch of Tempest Allograft Bone Matrix. This product launch marked a significant milestone for spine WAVE, providing surgeons with a novel solution for bone grafting in spinal procedures. The introduction of Tempest reflects Spine Wave's commitment to innovation and its mission to improve surgical outcomes in spine surgery through cutting-edge technologies and products

Spinal Allografts Market Scope

The market is segmented on the basis of surgery, product, and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Surgery

• Open Spine Surgery
• Minimally Invasive Spine Surgery

Product

• Machined Bones Allograft
• Demineralized Bone Matrix

End-Users

• Hospitals
• Ambulatory Surgical Centers
• Others

Spinal Allografts Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, surgery, product, and end-users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.  

North America dominates the spinal allografts market primarily due to its rising geriatric population and the region's widespread adoption of cutting-edge medical technologies. With a growing number of elderly individuals experiencing spinal issues, there is a heightened demand for advanced treatment options such as spinal allografts. Additionally, the region's well-established healthcare infrastructure and favorable reimbursement policies further contribute to its dominance in this market. These factors collectively position North America as a frontrunner in catering to the evolving needs of patients requiring spinal interventions.

The Asia-Pacific is expected to experience significant growth in the forecast period, primarily driven by increasing health consciousness among its populace. As awareness about healthcare rises, there's a growing demand for advanced medical technologies across the region. This surge in demand is expected to fuel robust growth rates, outpacing other regions. Consequently, Asia-Pacific stands as a promising market for healthcare companies and innovators looking to capitalize on this trend and cater to the population's evolving needs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Spinal Allografts Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Exactech, Inc. (U.S.)
• Medtronic (Ireland)
• NuTech Spine, Inc. (U.S.)
• NuVasive, Inc. (U.S.)
• RTI Surgical (U.S.)
• Wright Medical Group N.V. (U.S.)
• Stryker (U.S.)
• Arthrex, Inc. (Germany)
• Zimmer Biomet (U.S.)
• Nvision Biomedical Technologies, Inc. (U.S.)
• Alphatec Spine, Inc. (U.S.)
• Osiris Therapeutics, Inc. (U.S.)
• AlloSource (U.S.)
• Globus Medical Inc. (U.S.)
• LifeNet Health (U.S.)
• AlloSource (U.S.)
• Bone Bank Allografts (U.S.)
• RTI Surgical Holdings, Inc. (U.S.)
• Xtant Medical Holdings, Inc. (U.S.)

SKU-52842